Name : CCM2/Malcavernin Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN4878041863
| Long name | CCM2/Malcavernin Primary Polyclonal Antibody |
| Also known as | CCM2/Malcavernin PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | CCM2/Malcavernin |
| Specificity | This is a highly specific antibody against CCM2/Malcavernin |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Malcavernin |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | CCM is caused by mutations in one of three genes: CCM1, CCM1 encodes the protein KRIT1, CCM2 encodes the protein Malcavernin and CCM3 shares its name with the protein it encodes, CCM2 or CCM3, Due to its lack of a nuclear export signal or nuclear localization signal, In addition, Isoform 1 represents the full length protein while isoform 2 contains an alternative four amino acid sequence rather than the first 10 residues of isoform 1, Like KRIT1, Malcavernin, Malcavernin is expresed in a variety of human organs including the arterial vascular endothelium, Malcavernin is expressed in various epithelial cells that are required for the formation of the blood-organ barrier, Malcavernin is localized to the cytoplasm but is known to shuttle to and from the nucleus, Two isoforms exist for Malcavernin, also designated cerebral cavernous malformations 2 protein, astrocytes and their foot processes, cerebral hemorrhages, headaches and focal neurologic deficits, is a scffolding protein for MEK kinase-3, it is believed that Malcavernin accomplishes this shuttling via an attachment to KRIT1, pyramidal neurons, seizures, which contains a nuclear localization signal, Cerebral cavernous malformation (CCM) is an autosomal dominant or sporadic neurovascular disease marked by vascular anomalies located mostly in the central nervous system that can cause stroke |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | CCM2_HUMAN, Ccm2, Cerebral cavernous malformation 2, Cerebral cavernous malformations 2 protein, MGC4067, MGC4607, MGC74868, Malcavernin, PP10187, C7orf22 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | CCM2/Malcavernin |
| Short name | CCM2/Malcavernin Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | cerebral cavernous malformation 2/Malcavernin (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | CCM2 and IDBG-15466 and ENSG00000136280 and 83605, CCM2 and IDBG-634072 and ENSBTAG00000008090 and 506450, Ccm2 and IDBG-148293 and ENSMUSG00000000378 and 216527, Cytoplasm, protein binding, this GO :0001568 and blood vessel development and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001885 and endothelial cell development and biological process this GO :0001944 and vasculature development and biological process this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0007229 and integrin-mediated signaling pathway and biological process this GO :0007507 and heart development and biological process this GO :0035264 and multicellular organism growth and biological process this GO :0043234 and protein complex and cellular component this GO :0045216 and cell-cell junction organization and biological process this GO :0048839 and inner ear development and biological process this GO :0048845 and venous blood vessel morphogenesis and biological process this GO :0051403 and stress-activated MAPK cascade and biological process this GO :0060039 and pericardium development and biological process this GO :0060837 and blood vessel endothelial cell differentiation and biological process this GO :0061154 and endothelial tube morphogenesis and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding, cerebral cavernous malformation 2 |
| Identity | 21708 |
| Gene | CCM2 |
| Long gene name | CCM2 scaffolding protein |
| Synonyms gene | C7orf22 |
| Synonyms gene name | chromosome 7 open reading frame 22 cerebral cavernous malformation 2 |
| Synonyms | MGC4607 OSM |
| Synonyms name | malcavernin osmosensing scaffold for MEKK3 |
| Locus | 7p13 |
| Discovery year | 2003-07-14 |
| GenBank acession | BC004903 |
| Entrez gene record | 83605 |
| Pubmed identfication | 9811928 |
| RefSeq identity | NM_031443 |
| Havana BLAST/BLAT | OTTHUMG00000129246 |
| Locus Specific Databases | LRG_664 |